Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Bevacizumab in Advanced Hepatocellular Carcinoma: NCT07813572 Clinical Landscape Report 2026
9 min read
Bevacizumab in Advanced Hepatocellular Carcinoma: NCT07813572 Clinical Landscape Report 2026
11 September 2026
NCT07813572 clinical landscape for Advanced Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
Read →
GDC-3280 in Idiopathic Pulmonary Fibrosis: NCT07719023 Clinical Landscape Report 2026
9 min read
GDC-3280 in Idiopathic Pulmonary Fibrosis: NCT07719023 Clinical Landscape Report 2026
11 September 2026
NCT07719023 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Recombinant human coagulation factor VIII-Fc fusion protein (Gensciences) in Hemophilia A: NCT07684898 Clinical Landscape Report 2026
9 min read
Recombinant human coagulation factor VIII-Fc fusion protein (Gensciences) in Hemophilia A: NCT07684898 Clinical Landscape Report 2026
11 September 2026
NCT07684898 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Tislelizumab in Locally Advanced Esophageal Squamous Cell Carcinoma: NCT07811752 Clinical Landscape Report 2026
9 min read
Tislelizumab in Locally Advanced Esophageal Squamous Cell Carcinoma: NCT07811752 Clinical Landscape Report 2026
11 September 2026
NCT07811752 clinical landscape for Locally Advanced Esophageal Squamous Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and dev…
Read →
Trastuzumab in Locally Advanced Gastroesophageal Junction Adenocarcinoma: NCT07802288 Clinical Landscape Report 2026
9 min read
Trastuzumab in Locally Advanced Gastroesophageal Junction Adenocarcinoma: NCT07802288 Clinical Landscape Report 2026
11 September 2026
NCT07802288 clinical landscape for Locally Advanced Gastroesophageal Junction Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context a…
Read →
Anlotinib Dihydrochloride in Glioblastoma Multiforme: NCT07811297 Clinical Landscape Report 2026
9 min read
Anlotinib Dihydrochloride in Glioblastoma Multiforme: NCT07811297 Clinical Landscape Report 2026
11 September 2026
NCT07811297 clinical landscape for Glioblastoma Multiforme: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
FL-091 in Microsatellite instability-high colorectal cancer: NCT07812805 Clinical Landscape Report 2026
9 min read
FL-091 in Microsatellite instability-high colorectal cancer: NCT07812805 Clinical Landscape Report 2026
11 September 2026
NCT07812805 clinical landscape for Microsatellite instability-high colorectal cancer: endpoints, sponsor, phase, geography, readouts, asset context and devel…
Read →
Pirtobrutinib in Diffuse Large B-Cell Lymphoma: NCT07812493 Clinical Landscape Report 2026
9 min read
Pirtobrutinib in Diffuse Large B-Cell Lymphoma: NCT07812493 Clinical Landscape Report 2026
11 September 2026
NCT07812493 clinical landscape for Diffuse Large B-Cell Lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Budesonide in Pulmonary Disease, Chronic Obstructive: NCT07804303 Clinical Landscape Report 2026
9 min read
Budesonide in Pulmonary Disease, Chronic Obstructive: NCT07804303 Clinical Landscape Report 2026
11 September 2026
NCT07804303 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
Read →
NNC0537-1482 in Kidney Failure, Chronic: NCT07808788 Clinical Landscape Report 2026
9 min read
NNC0537-1482 in Kidney Failure, Chronic: NCT07808788 Clinical Landscape Report 2026
11 September 2026
NCT07808788 clinical landscape for Kidney Failure, Chronic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Eribulin mesylate in Endometrial Carcinoma: NCT07811232 Clinical Landscape Report 2026
9 min read
Eribulin mesylate in Endometrial Carcinoma: NCT07811232 Clinical Landscape Report 2026
11 September 2026
NCT07811232 clinical landscape for Endometrial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Albumin-Bound Paclitaxel in Locally Advanced Cervical Carcinoma: NCT07811375 Clinical Landscape Report 2026
9 min read
Albumin-Bound Paclitaxel in Locally Advanced Cervical Carcinoma: NCT07811375 Clinical Landscape Report 2026
11 September 2026
NCT07811375 clinical landscape for Locally Advanced Cervical Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
Read →